Throughout the COVID-19 pandemic, diagnostic companies played a pivotal role by creating and distributing essential tests to identify the virus. They became frontline warriors, supplying vital diagnostic tools crucial for containment and guiding public health responses. Initially, these firms experienced a surge in demand for testing kits, leading to increased investor interest and investment in …